|
Volumn 15, Issue 9, 2009, Pages 1007-1009
|
Racial disparities in liver transplantation for hepatitis B: To be or not to be
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ANTIVIRUS AGENT;
HEPATITIS B ANTIBODY;
LAMIVUDINE;
NUCLEOSIDE ANALOG;
AFRICAN AMERICAN;
CAUCASIAN;
DISEASE SEVERITY;
EDITORIAL;
FOLLOW UP;
GRAFT SURVIVAL;
HEALTH CARE ACCESS;
HEALTH CARE POLICY;
HEALTH DISPARITY;
HEALTH INSURANCE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
LIVER CIRRHOSIS;
LIVER DISEASE;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MORTALITY;
PRIORITY JOURNAL;
RACE DIFFERENCE;
RECIPIENT;
RECURRENT INFECTION;
SURVIVAL RATE;
AFRICAN AMERICANS;
ASIAN AMERICANS;
CARCINOMA, HEPATOCELLULAR;
CONTINENTAL POPULATION GROUPS;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
HEALTH STATUS DISPARITIES;
HEALTHCARE DISPARITIES;
HEPATITIS B;
HUMANS;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER NEOPLASMS;
LIVER TRANSPLANTATION;
PATIENT SELECTION;
RECURRENCE;
RISK ASSESSMENT;
TIME FACTORS;
TREATMENT OUTCOME;
WAITING LISTS;
|
EID: 70350556828
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.21848 Document Type: Editorial |
Times cited : (1)
|
References (8)
|